NUR 7620 Module 6 Integrative Care Case: Exercise, Mindfulness and St John's Wort for Recurrent Depression Example

Running, Breathing and a Herbal Extract: Weighing Three Integrative Options to Keep a 52-Year-Old Librarian Out of a Fourth Depression

Student Name

M.S. in Nursing, Psychiatric Mental Health Nurse Practitioner, Thomas Edison State University

NUR-7620: Family System Psychopathology and Psychotherapeutics Across the Lifespan

Mentor Name

Month Day, Year

Running, Breathing and a Herbal Extract: Weighing Three Integrative Options to Keep a 52-Year-Old Librarian Out of a Fourth Depression

A Patient Who Wants to Stay Well

Ms. H., an invented patient, is 52 and works as a reference librarian in Montclair. Depression has come three times in her adult life, at 31, 44 and 50, and each time it lingered for months. The last was treated with escitalopram, and she has been well for a year. She asks whether she can stop the medication and stay well with "something more natural," mentioning running, which she gave up a decade ago, meditation, which her sister practices, and St John's wort, which a friend takes. With three prior episodes, her risk of another is high, so the question is not whether to prevent recurrence but how. This paper weighs her three options and builds a plan.

Why Not Simply Stay on Escitalopram?

Continuing her antidepressant is a reasonable choice, and the nurse practitioner says so. Maintenance medication lowers recurrence risk in people with several past episodes, and it has caused her few side effects. But she has reasons of her own: she dislikes the idea of lifelong medication, she notices a muted emotional range she associates with the drug, and she wants skills she can use herself. A plan that respects those reasons is more likely to be followed. The honest framing is that stopping carries some added risk, which the chosen alternatives are meant to offset, and that restarting is always open to her.

Exercise

Schuch et al. (2016) pooled 25 randomized trials of exercise for depression and found a large antidepressant effect after adjusting for publication bias, with most adjustments suggesting that bias had led earlier reviews to underestimate the benefit. The benefit was biggest in diagnosed major depression, with aerobic activity done at a moderate or hard pace, and when a trained exercise professional ran the sessions. Most trials were short and treated active depression rather than preventing recurrence, so the evidence supports exercise as a treatment more strongly than as maintenance.

Mindfulness-Based Cognitive Therapy

Mindfulness-based cognitive therapy combines mindfulness meditation with cognitive therapy techniques in an eight-week group program designed specifically to prevent depressive relapse. Kuyken et al. (2016) analyzed individual data from 1,258 patients across nine trials. Those who received the program had a lower risk of relapse over 60 weeks than those who did not, and a lower risk than those who received other active treatments, including maintenance antidepressants in some trials. The benefit did not depend on age, sex or education, and was larger in people with more severe residual symptoms at the start. This is the strongest evidence among her options for the outcome she cares about.

St John's Wort

Linde et al. (2008) reviewed 29 trials of St John's wort extracts for major depression. In the larger trials, extracts were more effective than placebo, and they performed about as well as standard antidepressants with fewer drop-outs for side effects. The results varied, and trials from German-speaking countries reported more favorable findings. The bigger concern is safety. The herb switches on the liver's CYP3A4 system and the gut's drug pump, so the body clears many medicines faster: birth control pills, blood thinners, certain heart and transplant drugs and several HIV treatments can all lose strength. Combined with an SSRI, it can cause serotonin syndrome. Product strength varies, since supplements are not regulated like medicines. Ms. H. takes a statin, which St John's wort can make less effective.

The Plan

Mindfulness-based cognitive therapy is the centerpiece, since it targets relapse directly. She enrolls in an eight-week group that meets two hours each week, with daily home practice of about 40 minutes. Exercise is added for its own benefits: she joins a supervised walking-to-running program three times a week at moderate intensity, starting at 30 minutes, which also supports her heart health. St John's wort is not recommended, because of its interaction with her statin, the risk of serotonin syndrome during any overlap with escitalopram and uncertain product quality.

Practice at Home

The mindfulness program asks for daily practice, and the plan makes it realistic. She practices before work in the library's quiet study room, using recorded guided sessions, and keeps a brief log. On days when 40 minutes is impossible, a three-minute breathing space counts. Her book club, which she values, is protected as a fixed weekly commitment, since social connection is part of staying well and its loss is one of her early warning signs.

The escitalopram taper begins only after she completes the eight-week group, so she has her new skills in place, and proceeds slowly over at least four weeks, with the option to pause if symptoms return. This sequence mirrors the trials in which mindfulness-based cognitive therapy supported tapering of maintenance medication.

Monitoring

Her PHQ-9 is checked monthly during the taper and every three months for two years. A written early warning plan lists her personal signs, such as waking at 4 a.m. and withdrawing from her book club, and what she will do: increase practice, contact the clinic and consider restarting medication. Her exercise log and practice minutes are reviewed at each visit.

If two of her warning signs appear together for more than a week, she will call rather than wait for the next scheduled visit.

Conclusion

Of Ms. H.'s three options, mindfulness-based cognitive therapy has the strongest evidence for preventing recurrence, exercise has strong evidence as a treatment and broader health benefits, and St John's wort, despite efficacy in active depression, carries interaction risks that rule it out for her. A plan that builds new skills before a slow taper, with a clear warning plan, respects her wish for a life without daily medication while protecting her against a fourth episode.

References

Kuyken, W., Warren, F. C., Taylor, R. S., Whalley, B., Crane, C., Bondolfi, G., Hayes, R., Huijbers, M., Ma, H., Schweizer, S., Segal, Z., Speckens, A., Teasdale, J. D., Van Heeringen, K., Williams, M., Byford, S., Byng, R., & Dalgleish, T. (2016). Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse: An individual patient data meta-analysis from randomized trials. JAMA Psychiatry, 73(6), 565-574. https://doi.org/10.1001/jamapsychiatry.2016.0076

Linde, K., Berner, M. M., & Kriston, L. (2008). St John's wort for major depression. Cochrane Database of Systematic Reviews, 2008(4), Article CD000448. https://doi.org/10.1002/14651858.CD000448.pub3

Schuch, F. B., Vancampfort, D., Richards, J., Rosenbaum, S., Ward, P. B., & Stubbs, B. (2016). Exercise as a treatment for depression: A meta-analysis adjusting for publication bias. Journal of Psychiatric Research, 77, 42-51. https://doi.org/10.1016/j.jpsychires.2016.02.023